Page 4 - Mac Mahon News Today

In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment response rates continued to improve...

In two of the largest Phase III trials conducted in hidradenitis suppurativa (HS), Cosentyx® (secukinumab) treatment response rates continued to improve beyond the primary endpoint analysis at Week 16

Indian Science Congress Association (ISCA) is a premier scientific organisation of India with headquarters at Kolkata, West Bengal. ISCA is the initiative

The debate over the future of an executive suite building owned by the village of Wellington has some small business owners worried.

THE Peoples Museum in Limerick is presenting a week-long exhibition launching this Saturday, November 19 at 2pm, based on the artwork of Brian Mac Mahon and th...

Novartis Cosentyx® shows clinically meaningful symptom improvements in patients with hidradenitis suppurativa in pivotal Phase III trials

Investegate announcements from NOVARTIS AG CHF0.50(REGD), Novartis Cosentyx® shows clinically meaningful symptom improvements in patients with hidradenitis suppurativa in pivotal Phase III trials

Results from two parallel trials show Cosentyx (secukinumab) demonstrated superior efficacy vs placebo with statistically significant improvement in hidradenitis suppurativa (HS) signs and symptoms1Safety

In his role as MC on May 4th, Dominic West will be introducing an eclectic line-up of speakers

Years ago a syndicated columnist described Saint Peter’s campus as ‘what you see is what you get.’ The words of Star Ledger (NJ) columnist emeritus Jerry Izenberg, still resonate today. Before...